Home iCare – What we already know
Saudi Journal of Ophthalmology, ISSN: 2542-6680, Vol: 38, Issue: 4, Page: 295-305
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
The only known modifiable risk factor for the development and progression of glaucoma is an increased intraocular pressure (IOP). Current follow‑up with Goldmann applanation tonometry (GAT) constitutes a suboptimal approach, given out‑of‑office IOP peaks and fluctuations will not be exposed. Self‑tonometry in the home environment could address this unmet need, detecting uncontrolled disease and potentially impacting further therapeutic management. Since recently, iCare HOME was developed as a handheld rebound tonometer for this purpose. The aim of this literature review is twofold. First, the accuracy of iCare HOME compared to GAT will be assessed, including evaluation of the influence of corneal characteristics and the mean IOP. Second, an overview of the reported feasibility and acceptance on the use of iCare HOME will be presented. The literature review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‑Analysis guidelines. Literature was searched on Medline (via Pubmed), Embase, Cochrane Library, and Web of Science (Core Collection) on April 10, 2023. A total of 187 records were identified after deduplication, of which 20 articles were included after full evaluation of their suitability. This study reported that iCare HOME has a moderate to good accuracy compared to GAT and a tendency to underestimate GAT, with a median underestimation of 1 mmHg, ranging from 2.66 mmHg underestimation to 2.08 mmHg overestimation. Success rates ranged between 67.5% and 100% with a median rate of 82.5%. Sufficient acceptance was demonstrated. In conclusion, self‑tonometry with iCare HOME constitutes an accurate, feasible, and accepted method for home monitoring of glaucoma, providing additional out‑of‑office IOP‑data, and increasing patient empowerment.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know